Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The board of Daiichi Sankyo Company has approved the implementation of an open offer for the acquisition of the common stock of Zenotech Laboratories, an India-based company that is engaged in the manufacture and trading of pharmaceuticals.
Subscribe to our email newsletter
In relation to the acquisition of Ranbaxy shares announced in June 2008, and in accordance with the legal requirements in India, Daiichi Sankyo is scheduled to implement an open offer for 20% shares in Zenotech, an affiliate of Ranbaxy.